Profile data is unavailable for this security.
About the company
Qingdao Haier Biomedical Co Ltd is a China-based company mainly engaged in the research and development (R&D), production and sales of biomedical low-temperature storage products. The Company's main businesses include: providing biomedical low-temperature storage solutions covering the whole temperature range for scenarios such as sample safety, drug and reagent safety, vaccine safety and blood safety, as well as automatic, intelligent and comprehensive upgrading based on user needs, and providing integrated solutions for Internet of Thing (IoT) scenarios covering a variety of biosafety products. The Company's products are sold to domestic and overseas markets.
- Revenue in CNY (TTM)2.24bn
- Net income in CNY358.01m
- Incorporated2005
- Employees2.64k
- LocationQingdao Haier Biomedical Co LtdNo. 280 Fengyuan Road, High-tech ZoneQINGDAO 266114ChinaCHN
- Phone+86 53 288935566
- Fax+86 53 288936010
- Websitehttps://www.haierbiomedical.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HOB Biotech Group Corp Ltd | 401.29m | 35.26m | 9.14bn | 550.00 | 258.28 | 11.20 | -- | 22.79 | 0.5614 | 0.5614 | 6.35 | 12.95 | 0.4102 | 1.37 | 8.23 | 729,609.80 | 3.60 | 9.94 | 4.33 | 12.10 | 61.87 | 65.30 | 8.79 | 19.53 | 0.9438 | 39.42 | 0.1192 | 32.59 | 23.10 | 14.38 | 13.64 | 3.34 | 46.19 | -- |
| Vcanbio Cell & Gene Engineering Corp Ltd | 1.59bn | 107.45m | 9.69bn | 2.21k | 87.94 | 2.68 | -- | 6.08 | 0.2354 | 0.2354 | 3.45 | 7.73 | 0.2977 | 1.90 | 2.59 | 721,260.30 | 1.90 | 1.13 | 2.68 | 1.61 | 68.10 | 67.76 | 6.38 | 3.84 | 1.48 | 7.89 | 0.0296 | 0.00 | 2.24 | 3.78 | -5.78 | 12.43 | -7.11 | -- |
| Shanghai Microport EP MedTech Co Ltd | 383.99m | 35.90m | 10.08bn | 577.00 | 280.68 | 5.82 | -- | 26.24 | 0.0763 | 0.0763 | 0.816 | 3.68 | 0.2081 | 1.30 | 7.04 | 665,493.30 | 1.95 | -- | 2.05 | -- | 57.86 | -- | 9.35 | -- | 13.82 | -- | 0.0109 | -- | 26.46 | -- | 85.17 | -- | -- | -- |
| Shenzhen YHLO Biotech Co Ltd | 1.90bn | 288.64m | 10.39bn | 1.76k | 36.25 | 3.91 | -- | 5.46 | 0.5026 | 0.5026 | 3.32 | 4.66 | 0.4842 | 1.07 | 4.58 | 1,081,307.00 | 5.85 | 16.43 | 7.46 | 24.16 | 63.98 | 53.26 | 12.08 | 20.01 | 1.28 | 9.13 | 0.2474 | 30.28 | -48.42 | 23.02 | -64.93 | 56.32 | 28.88 | -- |
| Qingdao Haier Biomedical Co Ltd | 2.24bn | 358.01m | 11.05bn | 2.64k | 30.83 | 2.57 | -- | 4.94 | 1.13 | 1.13 | 7.04 | 13.53 | 0.4018 | 5.12 | 6.38 | 848,473.70 | 6.56 | 11.49 | 8.29 | 15.22 | 47.82 | 49.98 | 16.34 | 25.20 | 2.53 | -- | 0.0316 | 26.53 | -20.36 | 22.07 | -32.41 | 28.94 | 20.64 | -- |
| Shinva Medical Instrument Co Ltd | 10.12bn | 692.34m | 11.11bn | 8.21k | 12.96 | 1.48 | -- | 1.10 | 1.41 | 1.41 | 18.31 | 12.34 | 0.6775 | 2.20 | 4.96 | 1,232,589.00 | 4.72 | 4.63 | 9.14 | 10.76 | 25.62 | 24.22 | 6.96 | 6.12 | 0.8303 | -- | 0.1637 | 15.91 | 7.87 | -0.5342 | 30.78 | 95.70 | -5.90 | 61.86 |
| Shandong Weigao Orthopaedic Devce Co Ltd | 1.28bn | 154.60m | 11.55bn | 2.21k | 74.83 | 2.95 | -- | 8.99 | 0.3858 | 0.3858 | 3.20 | 9.78 | 0.2524 | 0.6714 | 4.03 | 581,131.60 | 3.14 | 10.97 | 3.95 | 13.69 | 62.40 | 77.33 | 12.43 | 27.08 | 3.62 | -- | 0.0096 | 17.90 | -30.55 | 1.17 | -79.36 | -19.11 | -4.31 | -- |
| Shanghai Runda Medical Technology Co Ltd | 8.43bn | 40.27m | 11.91bn | 3.32k | 295.31 | 2.77 | -- | 1.41 | 0.0673 | 0.0673 | 13.61 | 7.17 | 0.5831 | 4.19 | 1.49 | 2,543,990.00 | 1.18 | 4.78 | 3.13 | 12.86 | 25.94 | 27.13 | 2.03 | 6.36 | 1.01 | 3.04 | 0.5609 | 12.43 | -12.84 | 8.93 | -34.58 | 0.8514 | 3.88 | 1.03 |
| Beijing Wandong Medical Technolgy Co Ltd | 1.40bn | 184.09m | 12.30bn | 1.06k | 66.79 | 2.60 | -- | 8.76 | 0.262 | 0.262 | 2.00 | 6.74 | 0.2647 | 2.76 | 4.01 | 1,325,746.00 | 3.50 | 5.30 | 3.91 | 6.21 | 38.83 | 45.21 | 13.22 | 16.46 | 9.48 | -- | 0.0179 | 35.82 | 10.30 | 5.32 | 7.51 | 4.22 | -16.66 | 5.39 |
| Shanghai MicroPort Edvcl MdTch Grp CoLtd | 1.27bn | 657.34m | 13.31bn | 908.00 | 19.85 | 3.42 | -- | 10.50 | 5.44 | 5.44 | 10.59 | 31.54 | 0.371 | 1.33 | 6.51 | 1,396,816.00 | 19.00 | 17.68 | 21.55 | 19.43 | 74.51 | 76.60 | 51.21 | 42.25 | 5.49 | -- | 0.0067 | 44.46 | 32.43 | 38.72 | 37.98 | 40.28 | 50.18 | -- |
Data as of Nov 22 2024. Currency figures normalised to Qingdao Haier Biomedical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
13.82%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| JPMorgan Asset Management (Asia Pacific) Ltd.as of 30 Sep 2024 | 9.80m | 3.08% |
| Schroder Investment Management (Hong Kong) Ltd.as of 31 Dec 2023 | 7.81m | 2.46% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 7.18m | 2.26% |
| Hwabao WP Fund Management Co., Ltd.as of 14 Aug 2024 | 5.21m | 1.64% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2024 | 2.99m | 0.94% |
| Lion Fund Management Co., Ltd.as of 30 Jun 2024 | 2.58m | 0.81% |
| Aegon-Industrial Fund Management Co., Ltd.as of 30 Jun 2024 | 2.48m | 0.78% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 2.40m | 0.76% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2024 | 1.75m | 0.55% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2024 | 1.70m | 0.54% |
More ▼
Data from 30 Jun 2024 - 11 Nov 2024Source: FactSet Research Systems Inc.
